INMB logo

INmune Bio (INMB) Shareholders Equity

Annual Shareholders Equity

$38.14 M
-$21.96 M-36.54%

December 31, 2023


Summary


Performance

INMB Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMBbalance sheetmetrics:

Quarterly Shareholders Equity

$38.67 M
+$1.59 M+4.30%

September 30, 2024


Summary


Performance

INMB Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMBbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

INMB Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-36.5%+4.3%
3 y3 years-1.6%+4.3%
5 y5 years+130.6%+4.3%

INMB Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-52.5%at low-51.8%+33.3%
5 y5-year-52.5%+61.5%-56.2%+78.3%
alltimeall time-52.5%>+9999.0%-56.2%+133.8%

INmune Bio Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$38.67 M(+4.3%)
Jun 2024
-
$37.08 M(+27.8%)
Mar 2024
-
$29.02 M(-23.9%)
Dec 2023
$38.14 M(-36.5%)
$38.14 M(-14.7%)
Sep 2023
-
$44.73 M(-11.7%)
Jun 2023
-
$50.65 M(-8.4%)
Mar 2023
-
$55.30 M(-8.0%)
Dec 2022
$60.10 M(-25.1%)
$60.10 M(-5.7%)
Sep 2022
-
$63.71 M(-8.9%)
Jun 2022
-
$69.93 M(-7.5%)
Mar 2022
-
$75.64 M(-5.7%)
Dec 2021
$80.22 M
$80.22 M(-9.1%)
Sep 2021
-
$88.25 M(+104.1%)
DateAnnualQuarterly
Jun 2021
-
$43.23 M(-32.0%)
Mar 2021
-
$63.56 M(+64.0%)
Dec 2020
$38.75 M(+64.1%)
$38.75 M(-6.0%)
Sep 2020
-
$41.21 M(+90.0%)
Jun 2020
-
$21.68 M(-3.2%)
Mar 2020
-
$22.41 M(-5.1%)
Dec 2019
$23.61 M(+42.7%)
$23.61 M(-4.4%)
Sep 2019
-
$24.71 M(-7.9%)
Jun 2019
-
$26.84 M(+17.4%)
Mar 2019
-
$22.86 M(+38.2%)
Dec 2018
$16.54 M(-8.6%)
$16.54 M(-5.3%)
Sep 2018
-
$17.47 M(-3.5%)
Dec 2017
$18.10 M(<-9900.0%)
$18.10 M
Dec 2016
-$149.20 K
-

FAQ

  • What is INmune Bio annual stockholders equity?
  • What is the all time high annual shareholders equity for INmune Bio?
  • What is INmune Bio annual shareholders equity year-on-year change?
  • What is INmune Bio quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for INmune Bio?
  • What is INmune Bio quarterly shareholders equity year-on-year change?

What is INmune Bio annual stockholders equity?

The current annual shareholders equity of INMB is $38.14 M

What is the all time high annual shareholders equity for INmune Bio?

INmune Bio all-time high annual stockholders equity is $80.22 M

What is INmune Bio annual shareholders equity year-on-year change?

Over the past year, INMB annual stockholders equity has changed by -$21.96 M (-36.54%)

What is INmune Bio quarterly stockholders equity?

The current quarterly shareholders equity of INMB is $38.67 M

What is the all time high quarterly shareholders equity for INmune Bio?

INmune Bio all-time high quarterly stockholders equity is $88.25 M

What is INmune Bio quarterly shareholders equity year-on-year change?

Over the past year, INMB quarterly stockholders equity has changed by +$1.59 M (+4.30%)